Ledger.Open graph →
SEC Form D · filed May 23, 2024

Lycia Therapeutics, Inc

Offering
$106.6M
Sold
$106.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Aetna Wun Trombley · South San Francisco, CAExec · DirectorLaurent Fischer · South San Francisco, CADirectorAndrew Gottesdiener · South San Francisco, CADirectorAetna Wun Trombley · South San Francisco, CAExec · DirectorClare Ozawa · SAN DIEGO, CADirectorWilliam Rieflin · New York, NYDirectorAndrew Gottesdiener · South San Francisco, CADirectorLaurent Fischer · Princeton, NJDirectorMing Fang · Baltimore, MDDirectorTim Anderson · South San Francisco, CADirectorClare Ozawa · SAN DIEGO, CADirectorTim Anderson · South San Francisco, CADirectorWilliam Rieflin · New York, NYDirectorMing Fang · Baltimore, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗